BOSTON SCIENTIFIC CORP — Director's Dealing 2021

Jul 6, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2021-07-01

Reporting Person: Scanlon Meghan (SVP,Pres,Urology Pelvic Health)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-07-01	Common Stock	M	855.0000	$0.0000	Acquired	18685.0000	Direct
2021-07-01	Common Stock	F	251.0000	$43.3600	Disposed	18434.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-01	Deferred Stock Units	$	M	855.0000	Disposed	2021-07-01	Common Stock (855.0000)	Direct

Footnotes

F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on July 1, 2017, the first anniversary of the date of grant.